VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients


Ozgon G. O. , Langaee T. Y. , feng h., Buyru N. , Ulutin T., Hatemi A. C. , ...Daha Fazla

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, cilt.64, ss.889-894, 2008 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 64 Konu: 9
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1007/s00228-008-0507-5
  • Dergi Adı: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • Sayfa Sayıları: ss.889-894

Özet

Objectives The objective of this study was to determine the quantitative influence of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP 2C9) polymorphisms on warfarin dose requirements in Turkish patients.